What is a common adverse reaction to using bronchodilators?

Tachycardia is a well-recognized adverse reaction associated with bronchodilators, particularly those in the beta-agonist class, such as albuterol. These medications stimulate beta-adrenergic receptors in the airway smooth muscle, leading to bronchodilation and improved airflow. However, they can also stimulate beta receptors in the heart, resulting in an increased heart rate.

This side effect is particularly notable in patients receiving high doses or those who are sensitive to sympathomimetic agents. While tachycardia is impactful, it is important for nursing personnel to monitor and understand its occurrence in the context of the therapeutic benefits of bronchodilators in managing respiratory conditions. Other options provided usually do not have the same strong correlation with bronchodilator medications in typical clinical scenarios.